Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Blood|February 13, 2019
Myelofibrosis osteoclasts are clonal and functionally impairedIvo Veletic, Taghi Manshouri, Asha S Multani, et al.
Cell Death & Disease|May 20, 2022
GLI1 activates pro-fibrotic pathways in myelofibrosis fibrocytesTaghi Manshouri, Ivo Veletic, Ping Li, et al.
Cancer|January 9, 2003
The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndromeDi Lu, Randa Nounou, Miloslav Beran, et al.
Investigational New Drugs|April 8, 2010
Preclinical characterization of atiprimod, a novel JAK2 AND JAK3 inhibitorAlfonso Quintás-Cardama, Taghi Manshouri, Zeev Estrov, et al.
Molecular Cancer Therapeutics|March 1, 2013
Dual PI3K/AKT/mTOR inhibitor BEZ235 synergistically enhances the activity of JAK2 inhibitor against cultured and primary human myeloproliferative neoplasm cellsWarren Fiskus, Srdan Verstovsek, Taghi Manshouri, et al.
Leukemia Research|November 18, 2008
Imatinib has limited therapeutic activity for hypereosinophilic syndrome patients with unknown or negative PDGFRalpha mutation statusNitin Jain, Jorge Cortes, Alfonso Quintás-Cardama, et al.
Blood Advances|January 4, 2018
Therapy-related myelofibrosis does not appear to existLucia Masarova, Gabriele Todisco, Taghi Manshouri, et al.
European Journal of Haematology|September 3, 2003
Molecular differences between small and large cells in patients with chronic lymphocytic leukemiaJeong N Lee, Fancis Giles, Yang O Huh, et al.
Leukemia Research|February 6, 2009
Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosisArturo Vega-Ruiz, Jorge E Cortes, Matjaz Sever, et al.
Plos One|October 1, 2019
Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytesTaghi Manshouri, Srdan Verstovsek, David M Harris, et al.
Pageof 9